- Home
- BHVN vs CRTO Comparison
BHVN vs CRTO Comparison
Compare BHVN & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- CRTO
- Stock Information
- Founded
- BHVN 2013
- CRTO 2005
- Country
- BHVN United States
- CRTO France
- Employees
- BHVN N/A
- CRTO N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- BHVN Health Care
- CRTO Consumer Discretionary
- Exchange
- BHVN Nasdaq
- CRTO Nasdaq
- Market Cap
- BHVN 1.5B
- CRTO 1.2B
- IPO Year
- BHVN 2017
- CRTO 2013
- Fundamental
- Price
- BHVN $13.85
- CRTO $21.95
- Analyst Decision
- BHVN Strong Buy
- CRTO Buy
- Analyst Count
- BHVN 15
- CRTO 9
- Target Price
- BHVN $56.07
- CRTO $39.11
- AVG Volume (30 Days)
- BHVN 2.1M
- CRTO 298.6K
- Earning Date
- BHVN 11-11-2025
- CRTO 10-29-2025
- Dividend Yield
- BHVN N/A
- CRTO N/A
- EPS Growth
- BHVN N/A
- CRTO 44.35
- EPS
- BHVN N/A
- CRTO 2.38
- Revenue
- BHVN N/A
- CRTO $1,946,032,000.00
- Revenue This Year
- BHVN N/A
- CRTO N/A
- Revenue Next Year
- BHVN $2,002.87
- CRTO $2.19
- P/E Ratio
- BHVN N/A
- CRTO $9.51
- Revenue Growth
- BHVN N/A
- CRTO N/A
- 52 Week Low
- BHVN $12.79
- CRTO $21.44
- 52 Week High
- BHVN $55.70
- CRTO $47.27
- Technical
- Relative Strength Index (RSI)
- BHVN 40.24
- CRTO 33.54
- Support Level
- BHVN $13.63
- CRTO $21.44
- Resistance Level
- BHVN $17.05
- CRTO $23.80
- Average True Range (ATR)
- BHVN 0.87
- CRTO 0.79
- MACD
- BHVN -0.23
- CRTO -0.25
- Stochastic Oscillator
- BHVN 4.42
- CRTO 5.26
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.